UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Unique variants in CLCN3, encoding an endosomal anion/proton exchanger, underlie a spectrum of neurodevelopmental disorders

American journal of human genetics, 2021-08, Vol.108 (8), p.1450-1465

2021

Volltextzugriff (PDF)

Quality improvement: The tools we need to improve care for patients with inborn errors of metabolism

Molecular genetics and metabolism, 2020-01, Vol.129 (1), p.1-2

Kritzer, Amy

2020

Volltextzugriff (PDF)

Early initiation of enzyme replacement therapy in classical Fabry disease normalizes biomarkers in clinically asymptomatic pediatric patients

Molecular genetics and metabolism reports, 2019-12, Vol.21, p.100530, Article 100530

2019

Volltextzugriff (PDF)

First 1.5 years of pegvaliase clinic: Experiences and outcomes

Molecular genetics and metabolism reports, 2020-09, Vol.24, p.100603-100603, Article 100603

2020

Volltextzugriff (PDF)

Reinstitution of pegvaliase therapy during lactation

Molecular genetics and metabolism reports, 2022-12, Vol.33, p.100938, Article 100938

2022

Volltextzugriff (PDF)

Use of skimmed breast milk for an infant with a long‐chain fatty acid oxidation disorder: A novel therapeutic intervention

JIMD reports, 2020-09, Vol.55 (1), p.44-50

2020

Volltextzugriff (PDF)

Discontinuation of Pegvaliase therapy during maternal PKU pregnancy and postnatal breastfeeding: A case report

Molecular genetics and metabolism reports, 2020-03, Vol.22, p.100555, Article 100555

2020

Volltextzugriff (PDF)

P041: Real-world major clinical events and healthcare resource use among patients with long-chain fatty acid oxidation disorders in the United States

Genetics in Medicine Open, 2023, Vol.1 (1), p.100051, Article 100051

2023

Volltextzugriff (PDF)

P001: Single center experience with the Massachusetts State Newborn Screening Pilot Program for mucopolysaccharidosis type I, Pompe disease and X-linked adrenoleukodystrophy

Genetics in Medicine Open, 2023, Vol.1 (1), p.100011, Article 100011

2023

Volltextzugriff (PDF)

Pegvaliase treatment for adolescents with phenylketonuria: Clinical experience and discontinuation patterns

Molecular genetics and metabolism, 2024-04, Vol.141 (4), p.108270, Article 108270

2024

Volltextzugriff (PDF)

Standard operating procedure for genetic and metabolic consults for possible non-accidental trauma

Molecular genetics and metabolism, 2021-04, Vol.132, p.S103-S104

2021

Volltextzugriff (PDF)

eP156 - Standard operating procedure for genetic and metabolic consults for possible non-accidental trauma

Molecular genetics and metabolism, 2021-04, Vol.132, p.S103-S104

2021

Volltextzugriff (PDF)

Standardizing genetic and metabolic consults for non-accidental trauma at a large pediatric academic center

Child abuse & neglect, 2022-03, Vol.125, p.105480-105480, Article 105480

2022

Volltextzugriff (PDF)

A 4-Month-Old With Jaundice, Lethargy, and Emesis

Pediatrics (Evanston), 2024-10, Vol.154 (4), p.1

2024

Volltextzugriff (PDF)

eP516 - Patterns of healthcare utilization in a pediatric genetic cohort

Molecular genetics and metabolism, 2021-04, Vol.132, p.S333-S334

2021

Volltextzugriff (PDF)

Patterns of healthcare utilization in a pediatric genetic cohort

Molecular genetics and metabolism, 2021-04, Vol.132, p.S333-S334

2021

Volltextzugriff (PDF)

Rare diseases, common barriers: disparities in pediatric clinical genetics outcomes

Pediatric research, 2023-01, Vol.93 (1), p.110-117

2023

Volltextzugriff (PDF)

Ethical and psycho-social implications of mucopolysaccharidosis type I identified by newborn screening in the complex care setting

Molecular genetics and metabolism, 2020-02, Vol.129 (2), p.S96-S97

2020

Volltextzugriff (PDF)

A novel nonsense variant in the NFE2L1 transcription factor in a patient with developmental delay, hypotonia, genital anomalies, and failure to thrive

Human mutation, 2022-04, Vol.43 (4), p.471-476

2022

Volltextzugriff (PDF)

OP060: Rare diseases, common barriers: Disparities in clinical genetics outcomes

Genetics in medicine, 2022-03, Vol.24 (3), p.S386-S386

2022

Volltextzugriff (PDF)

eP495: Introduction to Odyssey: Real-world rare disease data collection program for patients with long-chain fatty acid oxidation disorders in the US

Genetics in medicine, 2022-03, Vol.24 (3), p.S315-S315

2022

Volltextzugriff (PDF)

Major clinical events and healthcare resource use among patients with long-chain fatty acid oxidation disorders in the United States: Results from LC-FAOD Odyssey program

Molecular genetics and metabolism, 2024-05, Vol.142 (1), p.108350-108350, Article 108350

2024

Volltextzugriff (PDF)

Early initiation of enzyme replacement therapy in pediatric Fabry disease

Molecular genetics and metabolism, 2018-02, Vol.123 (2), p.S25-S25

2018

Volltextzugriff (PDF)

Pathogenic SPTBN1 variants cause an autosomal dominant neurodevelopmental syndrome

Nature genetics, 2021-07, Vol.53 (7), p.1006-1021

2021

Volltextzugriff (PDF)

1 – 25 von 53

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(46)
Mit Volltextzugriff
(46)

Publikationsform

Sprache

Englisch
(53)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Unique variants in CLCN3, encoding an endosomal anion/proton exchanger, underlie a spectrum of neurodevelopmental disorders

Quality improvement: The tools we need to improve care for patients with inborn errors of metabolism

Early initiation of enzyme replacement therapy in classical Fabry disease normalizes biomarkers in clinically asymptomatic pediatric patients

First 1.5 years of pegvaliase clinic: Experiences and outcomes

Reinstitution of pegvaliase therapy during lactation

Implementation of rapid genomic sequencing in safety-net neonatal intensive care units: protocol for the VIrtual GenOme CenteR (VIGOR) proof-of-concept study

Use of skimmed breast milk for an infant with a long‐chain fatty acid oxidation disorder: A novel therapeutic intervention

Discontinuation of Pegvaliase therapy during maternal PKU pregnancy and postnatal breastfeeding: A case report

P041: Real-world major clinical events and healthcare resource use among patients with long-chain fatty acid oxidation disorders in the United States

P001: Single center experience with the Massachusetts State Newborn Screening Pilot Program for mucopolysaccharidosis type I, Pompe disease and X-linked adrenoleukodystrophy

Pegvaliase treatment for adolescents with phenylketonuria: Clinical experience and discontinuation patterns

Standard operating procedure for genetic and metabolic consults for possible non-accidental trauma

eP156 - Standard operating procedure for genetic and metabolic consults for possible non-accidental trauma

Standardizing genetic and metabolic consults for non-accidental trauma at a large pediatric academic center

A 4-Month-Old With Jaundice, Lethargy, and Emesis

eP516 - Patterns of healthcare utilization in a pediatric genetic cohort

Patterns of healthcare utilization in a pediatric genetic cohort

Rare diseases, common barriers: disparities in pediatric clinical genetics outcomes

Ethical and psycho-social implications of mucopolysaccharidosis type I identified by newborn screening in the complex care setting

A novel nonsense variant in the NFE2L1 transcription factor in a patient with developmental delay, hypotonia, genital anomalies, and failure to thrive

OP060: Rare diseases, common barriers: Disparities in clinical genetics outcomes

eP495: Introduction to Odyssey: Real-world rare disease data collection program for patients with long-chain fatty acid oxidation disorders in the US

Major clinical events and healthcare resource use among patients with long-chain fatty acid oxidation disorders in the United States: Results from LC-FAOD Odyssey program

Early initiation of enzyme replacement therapy in pediatric Fabry disease

Pathogenic SPTBN1 variants cause an autosomal dominant neurodevelopmental syndrome

Suchergebnisse filtern